2026 Pricing Guide
Pharmaceutical & Life Sciences
Series B
Data last verified: January 2026
Vulnerability Assessment for Series B Pharmaceutical & Life Sciences Companies
Series B pharmaceutical & life sciences companies typically invest $3K-$14K in vulnerability assessment. Get quotes from vetted providers in 24 hours.
$3K-$14K
Adjusted for Pharmaceutical & Life Sciences • Series B
1-3 daysMonthly or quarterly
Pricing verified Q1 202645+ vendor interviews127+ data sourcesUpdated monthly
Pharmaceutical & Life Sciences Snapshot
Pharmaceutical companies and biotech firms
Clinical trial data protection
IP theft prevention
FDA validation requirements
Series B Buying Behavior
Growth-stage companies scaling rapidly
Priorities: Comprehensive security program, Dedicated security hire
Typical budget: $50,000-$150,000
Buying behavior: Building security team, need program not projects, CISO/VP decision
Why Pharmaceutical & Life Sciences (Series B) buys Vuln Scan
Coverage: Internal, external, web apps
Scanning depth: Authenticated vs unauthenticated
Reporting: Prioritized remediation guidance
FAQs
How much does vulnerability assessment cost?
Vulnerability Assessment typically costs $2K-$10K depending on scope and complexity. For pharmaceutical & life sciences companies, expect to pay $3K-$14K due to FDA 21 CFR Part 11 and HIPAA requirements.
How long does vulnerability assessment take?
A typical vulnerability assessment engagement takes 1-3 days. Timeline depends on scope, organization size, and complexity of the environment.
How often should you do vulnerability assessment?
Monthly or quarterly. Compliance frameworks like PCI DSS and SOC 2 often require regular testing.
What certifications should vulnerability assessment providers have?
Look for providers with relevant industry experience, client references, and a proven methodology.
What should I look for when buying vulnerability assessment?
Key factors include: Coverage: Internal, external, web apps; Scanning depth: Authenticated vs unauthenticated; Reporting: Prioritized remediation guidance. Avoid vendors who marketed as penetration testing.
Ready for Vuln Scan quotes tailored to Pharmaceutical & Life Sciences (Series B)?
Get matched with vetted providers and receive pricing within 24 hours.